Project Grant R01HD112407
- Federal Project Grant Award Summary Rutgers, The State University received a $116,766 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 1, 2025, with completion targeted for August 31, 2028. The research project, conducted at the university's Piscataway, New Jersey facility, focuses on defining long-term neurological...
- Summary of Federal Project Grant Award The National Institute of Child Health and Human Development (NICHD) awarded $844,250 to the University of Nebraska Medical Center (UNMC) under the Child Health and Human Development Extramural Research program (CFDA 93.865) on July 1, 2025, for a two-year project period concluding June 30, 2027. The research initiative addresses critical gaps in understanding potential neurodevelopmental harms caused by antiretroviral (ARV) exposure in utero among the...
- Federal Cooperative Agreement Summary The National Institute of Mental Health awarded a $7.01 million Cooperative Agreement under the Mental Health Research Grants program (CFDA 93.242) to Massachusetts General Hospital for the SPARC-XP (Scalable Phenotyping to Assay Risk in Childhood After Exposures in Pregnancy) project. This four-year initiative (September 1, 2025 – August 31, 2029) will develop and validate predictive risk models to identify which offspring of mothers with infections...
- Federal Cooperative Agreement Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $12.84 million Cooperative Agreement to Harvard T.H. Chan School of Public Health on September 12, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to conduct the Pediatric HIV/AIDS Cohort Study (PHACS): Research on Immune Aging, Sexual and Reproductive Health, and Perinatal Acquisition: Elucidating Relationships in HIV (RISE). The five-year program,...
- This National Science Foundation (NSF) Project Grant award, funded under the Social, Behavioral, and Economic Sciences program (CFDA 47.075), aims to investigate the role of human behavior in the dynamics of mosquito-borne diseases such as dengue and Zika. The $100,000 grant, awarded to North Carolina State University (NC State), will support a multidisciplinary research project to understand how individual decision-making around mosquito prevention behaviors impacts disease transmission. The...
- Cooperative Agreement Summary Boston Children's Hospital, in partnership with the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), received a cooperative agreement award of $1.67 million on September 25, 2025, to conduct a Phase 1 clinical study evaluating a novel messenger RNA (mRNA)-lipid nanoparticle (LNP)-based SARS-CoV-2 vaccine incorporating controlled biodistribution technology and interleukin-12...
- Federal Project Grant Summary: ZCHAD Study The University of Michigan received a $176,583 Project Grant award from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), effective March 1, 2026, through February 29, 2028. The grant funds the Zambian Cohort of Healthy Aging and Dementia (ZCHAD) Study, a population-based research initiative designed to assess the prevalence of Alzheimer's disease and Alzheimer's disease-related...
- Federal Cooperative Agreement Summary Cincinnati Children's Hospital Medical Center received a $3.94 million Cooperative Agreement from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded May 1, 2025, with completion scheduled for April 30, 2029. The award funds a multi-site Phase 3 randomized controlled clinical trial (RCT) examining "Epilepsy Journey,"...
- Federal Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded Arkansas Children's Research Institute a $1.39 million Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) effective July 1, 2025, through May 31, 2030. The award funds the ELECTRA Pregnancy Study, which evaluates maternal and neonatal pharmacokinetics of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulators...
- Grant Award Summary Cincinnati Children's Hospital Medical Center received a $803,854 Project Grant award dated June 1, 2025, from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award supports research through March 31, 2030, investigating the functions of long terminal repeat (LTR) retrotransposon activation during preimplantation embryonic development. The project aims to determine...
CLINICAL PROGRESSION AND PREDICTORS OF OUTCOMES IN CONGENITAL ZIKA SYNDROME - PROJECT SUMMARY/ABSTRACT ALTHOUGH RATES OF CONGENITAL ZIKA VIRUS SYNDROME (CZS) HAVE DECLINED SINCE THE 2015-2016 ZIKA VIRUS (ZIKV) OUTBREAK IN BRAZIL, TRANSMISSION OF THE VIRUS STILL OCCURS, WITH NEARLY 9,000 CASES REPORTED ALREADY IN 2023. WITHOUT GLOBAL ERADICATION, THE THREAT OF ANOTHER LARGE OUTBREAK EXISTS. LONGITUDINAL RESEARCH IS NECESSARY TO BETTER UNDERSTAND THE LONG-TERM IMPACT OF CZS AND FACTORS ASSOCIATED WITH VARIOUS HEALTH OUTCOMES. FOR THIS APPLICATION, WE WILL EXTEND OUR SUCCESSFUL COLLABORATION BETWEEN RTI INTERNATIONAL AND ALTINO VENTURA FOUNDATION (FAV), TO INCLUDE THE UNIVERSITY OF NORTH CAROLINA AND PURDUE UNIVERSITY TO BRING NEW, EXPANDED EXPERTISE IN IMAGING, EEG, AND HEART RATE SUSTAINED ATTENTION. WE WILL CONTINUE TO EVALUATE THE IMPACT OF SEVERE CZS ON THE MEDICAL AND DEVELOPMENTAL OUTCOMES FOR 187 CHILDREN WHO HAVE BEEN FOLLOWED SINCE BIRTH. OUR COHORT, NOW ENTERING MIDDLE CHILDHOOD, IS THE LARGEST SAMPLE OF CHILDREN WITH WELL- DOCUMENTED CZS TO BE FOLLOWED LONGITUDINALLY SINCE INFANCY. WE WILL EXAMINE THE EVOLUTION OF THE PRIMARY CLINICAL SIGNS OF CZS (BRAIN, OCULAR, ORTHOPEDIC) AND ASSESS THE LONG-TERM MEDICAL, DEVELOPMENTAL, AND MENTAL HEALTH OUTCOMES FOR CHILDREN WITH CZS AND THEIR FAMILIES USING INNOVATIVE APPROACHES, SUCH AS A NOVEL HEART-RATE VARIABILITY PARADIGM, THAT ADDRESS SPECIFIC CHALLENGES IN ACCURATELY ASSESSING THE DEVELOPMENT OF CHILDREN WITH SEVERE DISABILITIES. LASTLY, WE WILL EXAMINE MALLEABLE PREDICTORS OF OUTCOMES FOR CHILDREN AND THEIR FAMILIES. THIS STUDY HAS THE POTENTIAL TO CONTRIBUTE TO GLOBAL KNOWLEDGE THAT COULD LEAD TO IMPROVED OUTCOMES FOR CHILDREN AND FAMILIES LIVING WITH CZS AND FOR CHILDREN IMPACTED BY OTHER CONDITIONS WITH SIMILAR CLINICAL FINDINGS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $636.1k | 4/22/25 | ||
| Not listed | $0 | 11/22/24 | ||
| Not listed | $0 | 11/22/24 | ||
| Not listed | $612.7k | 7/30/24 | ||
| Not listed | $612.7k | 7/30/24 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
13120219696MOD1S | University Of North Carolina At Chapel Hill | Project Grant R01HD112407 | $39.9k | 7/30/25 | |
33120219696MOD1S | Fundacao Altino Ventura | Project Grant R01HD112407 | $202.2k | 7/30/25 | |
33120219696INITIALAWARDS | Fundacao Altino Ventura | Project Grant R01HD112407 | $194.5k | 4/22/25 | |
23120219696INITIALAWARDS | Purdue University | Project Grant R01HD112407 | $104.0k | 4/22/25 |